Samsung

Samsung Biologics and Pfizer in Biosimilars Pact

South Korean CDMO Samsung Biologics has entered into a long-term manufacturing partnership with major drugmaker Pfizer.

Glenfarne and Samsung Link on Chile Hydrogen Fuels

US energy and infrastructure developer Glenfarne Energy Transition has entered into a collaboration with South Korean contractor Samsung Engineering to conduct feasibility studies for multiple green hydrogen and ammonia projects in Chile.

GreenLight and Samsung Achieve Commercial mRNA Run

The strategic partnership of Boston-based US biotech GreenLight Biosciences and Korean CDMO Samsung Biologics has completed the first commercial-scale engineering run for its mRNA production.

Samsung Super Plant to Supply AstraZeneca

Korean CMO Samsung Biologics has signed on with AstraZeneca to support the UK drugmaker’s biologics therapeutics. The company will produce bulk drug substance and drug product for its customer at its new $2 billion Plant 3 facility in Incheon, South Korea, set to go on stream in 2022.

Air Products Wins Korean Oxy-Fuels Contract

Samsung Bioepis and Takeda in Biologics Pact

Axiall and Lotte Greenlight Louisiana Ethylene Plant

Lotte to Buy Samsung Chemicals Businesses

Samsung Sells Off Chemicals and Defense Assets

US and China Beckon to German Chemical Contractors

The Biosimilar Market

SGL and Samsung to Jointly Develop Carbon Fiber Composites

"Information-Tech" Chemicals

Stick to Your Strengths with Biosimilars

The Asian Century

The Chemical Plant of the Future

Solar Companies To Seek Deep Pockets In Downturn

Merck Cuts Sales Target, Cites Sluggish Demand in Consumer Electronics

Powering The Next Generation